AusBiotech, Australia’s leading national industry body representing more than 3,000 life sciences members, and Life Sciences Western Australia, the leading body representing life sciences in Western Australia (WA), have joined forces with a new Memorandum of Understanding (MoU) designed to help unlock growth opportunities through closer collaboration. This partnership aligns with a shared vision to elevate Australia’s position as a leader in biotechnology, medical technology, and health innovation on both state and national levels.

In an evolving global landscape where health advancements and technology are increasingly critical, this MoU lays the groundwork for a deeper advocacy between Western Australia's strengths in life sciences with the broader Australian ecosystem.

The partnership will facilitate strategic opportunities for knowledge-sharing, expand member networks, and create a stronger, unified voice advocating for Australia’s life sciences industry.

Rebekah Cassidy, CEO of AusBiotech, stated “Our new MoU with Life Sciences Western Australia reflects a shared commitment to building Australia’s life sciences capabilities. We need to be coordinated nationally and be aware of and responsive to global changes such as global health concerns, supply chain vulnerabilities, and aging populations. This collaboration will help us leverage Western Australia’s unique strengths and ensure that life sciences across Australia are connected and thriving.”

Tobias Schoep, CEO of Life Sciences Western Australia, added
"This is a significant milestone for Australia’s vibrant life sciences sector. As the peak body for life sciences in Western Australia, Life Sciences WA is dedicated to supporting and advocating for our members both locally and globally. Through our strengthened partnership with AusBiotech, we are better positioned to address national and global challenges, harnessing WA’s unique strengths in a strategic, unified approach."